Association of Proton Pump Inhibitor Use With Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study

被引:7
|
作者
Mehta, Raaj S. [1 ,2 ]
Kochar, Bharati [1 ,2 ]
Zhou, Zhen [3 ]
Broder, Jonathan C. [4 ]
Chung, Paget [1 ,2 ]
Yang, Keming [1 ,2 ]
Lockery, Jessica [4 ]
Fravel, Michelle [5 ,6 ]
Ryan, Joanne [4 ]
Mahady, Suzanne [4 ]
Orchard, Suzanne G. [4 ]
Mcneil, John J. [4 ]
Murray, Anne [4 ]
Woods, Robyn L. [4 ]
Ernst, Michael E. [5 ,6 ]
Chan, Andrew T. [1 ,2 ,7 ,8 ]
机构
[1] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Univ Tasmania, Menzies Inst Med Res, Hobart, Australia
[4] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Australia
[5] Univ Iowa, Coll Pharm, Dept Pharm Practice & Sci, Iowa City, IA USA
[6] Univ Iowa, Carver Coll Med, Dept Family Med, Iowa City, IA USA
[7] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA
[8] Harvard Med Sch, Massachusetts Gen Hosp, Gastroenterol Unit, 55 Fruit St, GRJ 825C, Boston, MA 02114 USA
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
Proton Pump Inhibitors; Dementia; Pharmacoepidemiology; Cognition; DISEASE; RISK;
D O I
10.1053/j.gastro.2023.05.052
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Prior studies have suggested that proton pump inhibitor (PPI) use is associated with increased risk of dementia; however, these have been limited by incomplete assessment of medication use and failure to account for confounders. Furthermore, prior studies have relied on claims-based diagnoses for dementia, which can lead to misclassification. We investigated the associations of PPI and histamine-2 receptor antagonist (H2RA) use with dementia and cognitive decline. METHODS: We conducted a post hoc analysis of ASPirin in Reducing Events in the Elderly (ASPREE), a randomized trial of aspirin in the United States and Australia, including 18,934 community-based adults >65 years of all races/ethnicities. Baseline and recent PPI and H2RA use were determined according to review of medications during annual in-person study visits. Incident dementia was defined according to Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, criteria. Secondaryendpoints include cognitive impairment, no dementia (CIND) and changes in cognition. Associations of medication use with dementia and CIND outcomes were examined using Cox proportional hazards models. Changes in cognitive test scores were examined using linear mixed-effects models.RESULTS: Baseline PPI use vs nonuse was not associated with incident dementia (multivariable hazard ratio, 0.88; 95% confidence interval, 0.72-1.08), CIND (multivariable hazard ratio, 1.00; 95% confidence interval, 0.92-1.09), or with changes in overall cognitive test scores over time (multivariable B, -0.002; standard error, 0.01; P 1/4 .85). Similarly, no associations were observed between H2RA use and all cognitive endpoints.CONCLUSIONS: In adults >65 years of age, PPI and H2RA use were not associated with incident dementia, CIND, or decline in cognition over time. These data provide reassurance about the safety of long-term use of PPIs among older adults.
引用
收藏
页码:564 / +
页数:10
相关论文
共 50 条
  • [31] The Influence of Amyloid Burden on Cognitive Decline over 2 years in Older Adults with Subjective Cognitive Decline: A Prospective Cohort Study
    Hong, Yun Jeong
    Park, Jeong Wook
    Lee, Si Baek
    Kim, Seong-Hoon
    Kim, Yongbang
    Ryu, Dong-Woo
    Park, Kyung Won
    Yang, Dong Won
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2022, 50 (05) : 437 - 445
  • [32] Association between willingness to exercise and incident disability in older adults: a prospective longitudinal cohort study
    Nakajima, Chika
    Tomida, Kouki
    Shimoda, Takahiro
    Kawakami, Ayuka
    Shimada, Hiroyuki
    EUROPEAN GERIATRIC MEDICINE, 2024, 15 (06) : 1683 - 1689
  • [33] Proton Pump Inhibitor Use and Dementia Risk
    Dublin, Sascha
    Gray, Shelly L.
    Walker, Rod L.
    Yu, Onchee
    Bowles, Erin J. Aiello
    Anderson, Melissa L.
    Crane, Paul K.
    Larson, Eric B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 454 - 455
  • [34] Association Between Proton Pump Inhibitor Use and Cognitive Function in Women
    Lochhead, Paul
    Hagan, Kaitlin
    Joshi, Amit D.
    Khalili, Hamed
    Nguyen, Long H.
    Grodstein, Francine
    Chan, Andrew T.
    GASTROENTEROLOGY, 2017, 153 (04) : 971 - +
  • [35] Associations of Height Loss With Cognitive Decline and Incident Dementia in Adults Aged 50 Years and Older
    Guo, Jing
    Song, Suhang
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2023, 78 (08): : 1445 - 1452
  • [36] Prescription Opioids and Risk of Dementia or Cognitive Decline: A Prospective Cohort Study
    Dublin, Sascha
    Walker, Rod L.
    Gray, Shelly L.
    Hubbard, Rebecca A.
    Anderson, Melissa L.
    Yu, Onchee
    Crane, Paul K.
    Larson, Eric B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 (08) : 1519 - 1526
  • [37] Social frailty and its association with cognitive trajectories in older adults: a prospective cohort study
    Zhang, Hui
    Hao, Meng
    Hu, Zixin
    Jiang, Shuai
    Li, Yi
    Wang, Xiaofeng
    Li, Xiangwei
    ALZHEIMERS RESEARCH & THERAPY, 2025, 17 (01)
  • [38] Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study
    Foresta, Andreana
    Fernandez, Luisa Ojeda
    Torrigiani, Ginevra
    Schena, Simone
    Roncaglioni, Maria Carla
    Nobili, Alessandro
    Tettamanti, Mauro
    Franchi, Carlotta
    Fortino, Ida
    Succurro, Elena
    Sesti, Giorgio
    Baviera, Marta
    DRUGS & AGING, 2024, 41 (03) : 239 - 249
  • [39] Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study
    Andreana Foresta
    Luisa Ojeda Fernandez
    Ginevra Torrigiani
    Simone Schena
    Maria Carla Roncaglioni
    Alessandro Nobili
    Mauro Tettamanti
    Carlotta Franchi
    Ida Fortino
    Elena Succurro
    Giorgio Sesti
    Marta Baviera
    Drugs & Aging, 2024, 41 : 239 - 249
  • [40] Regular use of proton pump inhibitor and risk of rheumatoid arthritis in women: a prospective cohort study
    Yuan, Jinqiu
    Zhang, Changhua
    Sparks, Jeffrey A.
    Malspeis, Susan
    Tsoi, Kelvin Kam-Fai
    Kim, Jean H.
    Fisher, Benjamin A.
    Gao, Fang
    Sumerlin, Tim
    Liu, Yan
    Liu, Yuxing
    Pan, Yihang
    He, Yulong
    Sung, Joseph J. Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (03) : 449 - 458